01 1Cambrex Corporation
01 1DEXTROAMPHETAMINE SULFATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-18
Pay. Date : 2012-12-12
DMF Number : 15307
Submission : 2001-02-26
Status : Active
Type : II
20
Cambrex Charles City Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is DEXTROAMPHETAMINE SULFATE USP, with a corresponding US DMF Number 15307.
Remarkably, this DMF maintains an Active status since its submission on February 26, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2013, and payment made on December 12, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
